An FDA panel of health experts voted 8-8 on whether to recommend market withdrawal of Abbott Laboratories' Meridia because of clinical evidence that the weight-loss drug increases the risk of heart disease. Panelists who favored keeping the drug suggested restricting sales or revising the warning label.

Full Story:

Related Summaries